Goal Attainment Scaling in Upper Limb Spasticity Treatment
GASBTX
1 other identifier
interventional
70
1 country
1
Brief Summary
Patients after stroke with upper limb spasticity treated with botulinum toxin-A (BTX-A) will be included in this two-part study. In the first part, goal attainment scaling and comprehensive assessment of motor functioning will be performed before BTX-A application and after two weeks. In the second part, the patients will be randomised into a test group performing prescribed regular exercise for two weeks and a control group exercising at their own discretion during the same period, whereby the patients' health-related quality of life will be assessed at the beginning and end of the two-week period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2021
CompletedFirst Submitted
Initial submission to the registry
February 15, 2021
CompletedFirst Posted
Study publicly available on registry
July 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
December 6, 2024
December 1, 2024
5.7 years
February 15, 2021
December 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
GAS-Light
Change in Goal Attainment Scale - Light
At baseline, after 2 weeks (i.e., at the end of the 1st part of the study)
SQoL-6D
Change in Spasticity Related Quality of Life Tool score
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
Secondary Outcomes (6)
ROM
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
MAS
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
PSFS
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
VAS
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
BSR
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
- +1 more secondary outcomes
Study Arms (2)
Test group
EXPERIMENTALPrescribed exercise program
Control group
NO INTERVENTIONExercising at patient's own discretion
Interventions
Active or passive exercises for the spastic upper limb, including functional electrical stimulation (FES), performed regularly for two weeks.
Eligibility Criteria
You may qualify if:
- patient's or caregiver's approval
- ischemic or hemorrhagic stroke diagnosed using head CT/MRI
- at least one upper limb muscle spasticity (MAS ≥ 3)
- candidate for BTX-A treatment or already given BTX-A in the past
- patient's or caregiver's capability for goal attainment protocol cooperation (Mini Mental Examination ≥ 24 points)
You may not qualify if:
- aphasic patients without caregiver's presence
- other neurological or musculoskeletal diseases that could affect the treatment outcome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Rehabilitation Institute, Republic of Slovenia
Ljubljana, 1000, Slovenia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nataša Bizovičar, MD, PhD
University Rehabilitation Institute, Republic of Slovenia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 15, 2021
First Posted
July 23, 2021
Study Start
January 3, 2021
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
December 6, 2024
Record last verified: 2024-12